A retrospective study to determine demographics and clinical characteristics of patients who started different asthma biologics treatment
Latest Information Update: 22 Jul 2022
At a glance
- Drugs Benralizumab (Primary) ; Dupilumab (Primary) ; Mepolizumab (Primary) ; Omalizumab (Primary) ; Reslizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
Most Recent Events
- 22 Jul 2022 New trial record